It looks like you have an older browser that is not supported by this site. Please click here to update.

Article Open to All

COVID-19 Monoclonal Antibody Access and Infusion

Posted Feb 8, 20211 min Read

Regulatory & Clinical

As the benefits of monoclonal antibody treatment continue to be released, IHCA/INCAL wants to be sure you are aware of the resources for infusions and access to the therapy itself if your community has ability to perform infusions of this treatment.  Please see below.

Home infusion in nursing homes and assisted living facilities

  • ​Home infusion providers in 46 states and DC will dispense and provide nursing support for administration of mAbs to residents of nursing homes and assisted living facilities
  • Partner: National Home Infusion Association

Direct allocation to long-term care pharmacies

  • ​Long-term care pharmacies will be pre-positioned with mAbs to deploy when cases occur in nursing homes and assisted living communities served by each pharmacy
  • Partners: American Society of Consultant Pharmacists and AMDA-The Society for Post-Acute and Long-Term Care Medicine

About the Author

Lori Davenport, Director of Regulatory and Clinical Affairs